John Diaz, discusses key targets for cervical cancer and ovarian cancer.
John P. Diaz, MD
Advertisement
John P. Diaz, MD, is the deputy chief of Gynecologic Oncology, and lead physician for Clinical Trials in Gynecologic Oncology at Miami Cancer Institute. He also serves as chief of the Center of Excellence in Minimally Invasive Gynecologic Surgery, at Baptist Health South Florida.
Articles by John P. Diaz, MD
John Diaz, MD, discusses some known biomarkers in ovarian cancer and where he hopes to see more research in the future.
John Diaz, MD, discusses potential innovations for the ovarian cancer space.
John P. Diaz, MD, discusses how meetings on gynecologic oncology provide advantages for everyday physicians to keep track of the latest updates on the treatment landscape.
John P. Diaz, MD, explains the importance of the topics to be discusses at the Miami Cancer Institute Women’s Cancer Symposium on April 21, 2023.
John P. Diaz, MD, provides an overview of the topics to be discusses during the Miami Cancer Institute Women’s Cancer Symposium on April 21, 2023.
The treatment of platinum-resistant ovarian cancer is challenging, with limited therapeutic options. Antibody-drug conjugates as single agents or in combinations are showing promise for these patients.
Advertisement
Latest Updated Articles
Clinical Research Drives Advances in Ovarian CancerPublished: October 24th 2021 | Updated:
Clinical Management Highlights for Gynecologic CancersPublished: April 18th 2023 | Updated:
- Evolving Topics Among Oncologists Treating Gynecologic Cancers
Published: April 19th 2023 | Updated:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
4
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
5
